Positron Emission Tomography in Esophageal Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Gonzalez-Stawinski G, Lemaire A, Merchant F, OHalloran E, Coleman R, Harpole D
. A comparative analysis of positron emission tomography and mediastinoscopy in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003; 126(6):1900-5.
DOI: 10.1016/s0022-5223(03)01036-5.
View
2.
Yang G, Wagner T, Jobe B, Thomas C
. The role of positron emission tomography in esophageal cancer. Gastrointest Cancer Res. 2009; 2(1):3-9.
PMC: 2630808.
View
3.
Ajani J, Bekaii-Saab T, DAmico T, Fuchs C, Gibson M, Goldberg M
. Gastric Cancer Clinical Practice Guidelines. J Natl Compr Canc Netw. 2006; 4(4):350-66.
DOI: 10.6004/jnccn.2006.0030.
View
4.
Kalff V, Hicks R, MacManus M, Binns D, McKenzie A, Ware R
. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol. 2001; 19(1):111-8.
DOI: 10.1200/JCO.2001.19.1.111.
View
5.
Pieterman R, Van Putten J, Meuzelaar J, Mooyaart E, Vaalburg W, Koeter G
. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med. 2000; 343(4):254-61.
DOI: 10.1056/NEJM200007273430404.
View